1-methyl-4-<1-methyl-4-(1-methyl-4-nitropyrrole-2-carboxamido)pyrrole-2-carboxamido>pyrrole-2-carboxamidopropionitrile | 2522-28-3

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 1-methyl-4-<1-methyl-4-(1-methyl-4-nitropyrrole-2-carboxamido)pyrrole-2-carboxamido>pyrrole-2-carboxamidopropionitrile
• 英文别名: β-(1-Methyl-4-<1-methyl-4-(1-methyl-4-nitro-pyrrol-2-carbonamido)-pyrrol-2-carbonamido>-pyrrol-2-carbonamido)-propionitril；N-[2-(azaniumylidynemethyl)ethyl]-1-methyl-4-[[1-methyl-4-[(1-methyl-4-nitropyrrole-2-carbonyl)amino]pyrrole-2-carbonyl]amino]pyrrole-2-carboximidate
• CAS: 2522-28-3
• 化学式: C₂₁H₂₂N₈O₅
• 分子量: 466.456
• InChiKey: MALNYUXANSMISF-UHFFFAOYSA-N

物化性质

• 熔点：
  270 °C
• 沸点：
  649.4±55.0 °C(Predicted)
• 密度：
  1.44±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.4
• 重原子数：
  34
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  172
• 氢给体数：
  3
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  1-methyl-4-<1-methyl-4-(1-methyl-4-nitropyrrole-2-carboxamido)pyrrole-2-carboxamido>pyrrole-2-carboxamidopropionitrile 在 palladium on activated charcoal 盐酸 、 乙醇 、 氨 、 氢气 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 、 甲醇 、 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 反应 2.5h， 生成 N,N'-Bis-(5-{5-[5-(2-carbamimidoyl-ethylcarbamoyl)-1-methyl-1H-pyrrol-3-ylcarbamoyl]-1-methyl-1H-pyrrol-3-ylcarbamoyl}-1-methyl-1H-pyrrol-3-yl)-succinamide; hydrochloride
  参考文献：
  名称：

  与Netropsin和Distamycin相关的新型抗病毒和抗肿瘤药物：合成和生物学评估。

  摘要：

  合成了一组寡肽，其在结构上与天然抗病毒抗肿瘤抗生素netropsin和distamycin有关，带有通过聚亚甲基桥连接的两个这样的部分。据报道，对人和鼠肿瘤细胞系均具有细胞抑制活性，并且它们对多种病毒具有体外活性。获得了针对牛痘病毒的增强的抗病毒活性。由于引入了多亚甲基接头[（CH2）n，n = 1、2和6-8]，与母体化合物netropsin和distamycin相比，其抗肿瘤和抗痘苗病毒的活性均显着增强。讨论了这些试剂的生物学活性，既涉及其结构差异，也涉及其与双链DNA的小沟结合。

  DOI：

  10.1021/jm00130a024
• 作为产物：
  描述：

  1-甲基-4-硝基吡咯-2-羧酸 在 palladium on activated charcoal 盐酸 、 氯化亚砜 、 氢气 、 1,8-双二甲氨基萘 、 N,N-二异丙基乙胺 、 N,N'-二环己基碳二亚胺 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 为溶剂， 反应 3.08h， 生成 1-methyl-4-<1-methyl-4-(1-methyl-4-nitropyrrole-2-carboxamido)pyrrole-2-carboxamido>pyrrole-2-carboxamidopropionitrile
  参考文献：
  名称：

  Efficient total syntheses of the oligopeptide antibiotics netropsin and distamycin

  摘要：

  DOI：

  10.1021/jo00220a019

文献信息

• Synthesis of Geometrically Constrained Unsymmetrical Bis(polyamides) Related to the Antiviral Distamycin
  作者：Sanjay K. Sharma、Manju Tandon、J. William Lown

  DOI：10.1002/1099-0690(200006)2000:11<2095::aid-ejoc2095>3.0.co;2-j

  日期：2000.6

  for the strict DNA base-sequence recognition of (AT)4 and (AT)5, respectively, for the oligopeptide minor-groove binding agents netropsin (I) and distamycin (II) leads to proposals for the rational structure modification for altered base recognition. In this paper we report the synthesis of unsymmetrical imidazo-pyrrolo-bis(polyamides), structurally related to the natural antiviral agents distamycin

  分析分别对（AT）4和（AT）5的寡肽小沟结合剂netropsin（I）和distamycin（II）的严格DNA碱基序列识别的结构和立体化学要求导致了对合理的结构修饰，以改变碱基识别。在本文中，我们报告了与天然抗病毒剂双歧霉素在结构上相关且带有非天然（25-27）或天然（31-33）的不对称咪唑并吡咯并双（聚酰胺）的合成）由柔性或刚性接头链接的末端。这是关于在连接的双（聚酰胺）中具有二甲基氨基丙基或am基末端的带有咪唑的结构的合成的首次报道。
• Acryloyl derivatives analogous to distamycin, process for preparing them, and their use as antitumor agents
  申请人：Pharmacia & Upjohn S.p.A.

  公开号：US06753316B1

  公开（公告）日：2004-06-22

  Compounds which are acryloyl substituted distamycin derivatives of formula (I) wherein: n is 2, 3 or 4; m is 1 or 2; X and Y are the same or different and are selected, independently for each heterocyclic ring of the polyetherocyclic chain, from N and CH; R1 and R2, which are the same or different, are selected from hydrogen, halogen, and C1-C4 alkyl; R3 is hydrogen or halogen; B is selected from (a), (b), (c), (d), (e), (f), (g) and —C≡N; wherein R4, R5, R6, R7, R8, R10, R11, and R12 are, independently from each other, hydrogen or C1-C4 alkyl; and R9 is hydrogen or hydroxy, or pharmaceutically acceptable salt thereof; provided that a) at least one of R4, R5 and R6 is alkyl b) at least one of the heterocyclic rings within the polyheterocyclic chain is other than pyrole; and c) X and Y are not both N for the same heterocyclic ring; are useful as antitumor agents.

  化合物是acryloyl取代的formula（I）的distamycin衍生物，其中：n为2、3或4；m为1或2；X和Y相同或不同，分别选自N和CH，为聚醚杂环链的每个杂环环；R1和R2相同或不同，选自氢、卤素和C1-C4烷基；R3为氢或卤素；B选自（a）、（b）、（c）、（d）、（e）、（f）、（g）和—C≡N；其中R4、R5、R6、R7、R8、R10、R11和R12独立地选自氢或C1-C4烷基；R9为氢或羟基，或其药用可接受的盐；条件是a）R4、R5和R6中至少有一个是烷基；b）聚杂环链内至少有一个杂环环不是吡咯；和c）X和Y对于相同的杂环环不同时为N；这些化合物可用作抗肿瘤剂。
• Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents
  申请人：Pharmacia & Upjohn, S.p.A.

  公开号：US06458768B1

  公开（公告）日：2002-10-01

  Compounds which are benzoheterocyclic distamycin derivatives of formula (I), wherein n is 2, 3 or 4; A is a heteroatom selected from O and S or is a group NR, wherein R is hydrogen or C1-C4 alkyl; B is CH or N; R1 is hydrogen or C1-C4 alkyl; G is selected from the group consisting of (a, b, c, d, e, f, g, h, i, j), and —C≡N; wherein R5, R6, R7, R8, R9, R10, R11 and R12 are, independently from each other, hydrogen or C1-C4 alkyl; T is a group of formula (II) or (III) as defined above, wherein p is 0 or 1; R2 and R3 are, independently from each other, hydrogen, C1-C4 alkyl optionally substituted by one or more fluorine atoms, or C1-C4 alkoxy; R4 is C1-C4 alkyl or C1-C3 haloalkyl; X1 and X2 are halogen atoms or pharmaceutically acceptable salts thereof; provided that at least one of R5, R6 and R7 is alkyl; are useful as antitumor agents.

  式(I)的苯并杂环二聚胺衍生物化合物，其中n为2、3或4；A为从O和S选择的杂原子或为NR基团，其中R为氢或C1-C4烷基；B为CH或N；R1为氢或C1-C4烷基；G从(a、b、c、d、e、f、g、h、i、j)和—C≡N组中选择；其中R5、R6、R7、R8、R9、R10、R11和R12独立地为氢或C1-C4烷基；T为式(II)或(III)中定义的基团，其中p为0或1；R2和R3独立地为氢、C1-C4烷基（可以被一个或多个氟原子取代）或C1-C4烷氧基；R4为C1-C4烷基或C1-C3卤代烷基；X1和X2为卤素原子或其药学上可接受的盐；至少其中一个R5、R6和R7为烷基。这些化合物可用作抗肿瘤剂。
• Structure-activity relationships of pyrrole amidine antiviral antibiotics. 2. Preparation of mono- and tripyrrole derivatives of congocidine
  作者：Meir Bialer、Boris Yagen、Raphael Mechoulam、Yechiel Becker

  DOI：10.1021/jm00184a018

  日期：1980.10

  virus (HSV) replication in cultured cells, and effects on the synthesis of HS DNA in isolated nuclei in vitro, as well as on DNA synthesis by purified HSV DNA polymerase. All synthesized tripyrrole derivatives of congocidine were less cytotoxic and more active than the parent drug in all the three ant iviral tests.

  合成了三种类型的刚果金（1）类似物的代表。测试了它们的细胞毒性，在培养细胞中对单纯疱疹病毒（HSV）复制的抑制以及对离体核中HS DNA合成的影响，以及纯化HSV DNA聚合酶对DNA合成的影响。在所有三个抗病毒试验中，所有合成的刚果金三吡咯衍生物的毒性都比母体药物小，活性更高。
• Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
  申请人：Pharmacia & Upjohn S.p.A.

  公开号：US20030023031A1

  公开（公告）日：2003-01-30

  According to the invention, there is provided a method of manufacturing a medicament for use in the treatment of cancer or viral infections which comprises obtaining a cancer treating effective amount of a compound of formula (I), 1 and combining the compound of formula (I) with at least one pharmaceutically acceptable excipient, and wherein the cancer treating effective amount of a compound of formula I is an acryloyl substituted distamycin derivative in which n, R 1 and R 2 , R 3 , B, are defined herein or a pharmaceutically acceptable salt thereof to produce a medicament for use in the treatment of cancer or viral infections.

  根据本发明，提供了一种制造治疗癌症或病毒感染的药物的方法，该方法包括获取公式（I）化合物的治疗癌症有效量，1并将公式（I）化合物与至少一种药用可接受的赋形剂结合，其中公式I化合物的治疗癌症有效量是一种丙烯酰基取代的二氨基链霉素衍生物，其中n，R1和R2，R3，B在此定义，或其药用可接受盐，以制备用于治疗癌症或病毒感染的药物。